Literature DB >> 27283932

Precision Nanomedicine Using Dual PET and MR Temperature Imaging-Guided Photothermal Therapy.

Min Zhou1,2,3, Marites Melancon4, R Jason Stafford5, Junjie Li1, Alpa M Nick6, Mei Tian2, Anil K Sood6,7, Chun Li8.   

Abstract

Imaging-based techniques have enabled the direct integration of noninvasive imaging with minimally invasive interventions such as photothermal therapy (PTT) to improve the precision of treatment.
METHODS: We investigated the feasibility of PTT for ovarian cancer under the guidance of PET and MR temperature imaging using copper sulfide nanoparticles (CuS NPs). The tumor distribution of the CuS NPs after systemic administration was assessed using highly sensitive, quantifiable PET imaging. Two wavelengths of near-infrared (NIR) lasers-808 and 980 nm-were tested for PTT using noninvasive MR temperature imaging real-time monitoring.
RESULTS: The in vivo studies revealed that the 980-nm NIR laser had better photothermal effects than the 808-nm NIR laser. These results were in accord with the histologic findings. In vivo PTT using CuS NPs combined with 980-nm laser irradiation achieved significant tumor ablation compared with no treatment control in both subcutaneous (P = 0.007) and orthotopic (P < 0.001) models of ovarian cancer with regard to the percentage of necrotic damage.
CONCLUSION: Our results indicate that real-time monitoring of the accuracy of PTT is a promising approach for future clinical translation of this emerging thermal ablation technique.
© 2016 by the Society of Nuclear Medicine and Molecular Imaging, Inc.

Entities:  

Keywords:  CuS nanoparticles; MRI; PET; ovarian cancer; photothermal therapy

Mesh:

Substances:

Year:  2016        PMID: 27283932      PMCID: PMC5093070          DOI: 10.2967/jnumed.116.172775

Source DB:  PubMed          Journal:  J Nucl Med        ISSN: 0161-5505            Impact factor:   10.057


  24 in total

Review 1.  Positron emission tomography molecular imaging for drug development.

Authors:  Paul M Matthews; Eugenii A Rabiner; Jan Passchier; Roger N Gunn
Journal:  Br J Clin Pharmacol       Date:  2012-02       Impact factor: 4.335

2.  Copper sulfide nanoparticles for photothermal ablation of tumor cells.

Authors:  Yuebin Li; Wei Lu; Qian Huang; Miao Huang; Chun Li; Wei Chen
Journal:  Nanomedicine (Lond)       Date:  2010-10       Impact factor: 5.307

3.  Magnetic resonance temperature imaging validation of a bioheat transfer model for laser-induced thermal therapy.

Authors:  D Fuentes; C Walker; A Elliott; A Shetty; J D Hazle; R J Stafford
Journal:  Int J Hyperthermia       Date:  2011       Impact factor: 3.914

Review 4.  Molecular imaging of prostate cancer with PET.

Authors:  Hossein Jadvar
Journal:  J Nucl Med       Date:  2013-10       Impact factor: 10.057

5.  Hydrophilic Cu9S5 nanocrystals: a photothermal agent with a 25.7% heat conversion efficiency for photothermal ablation of cancer cells in vivo.

Authors:  Qiwei Tian; Feiran Jiang; Rujia Zou; Qian Liu; Zhigang Chen; Meifang Zhu; Shiping Yang; Jinglong Wang; Jianhua Wang; Junqing Hu
Journal:  ACS Nano       Date:  2011-11-15       Impact factor: 15.881

6.  Theranostic probe for simultaneous in vivo photoacoustic imaging and confined photothermolysis by pulsed laser at 1064 nm in 4T1 breast cancer model.

Authors:  Min Zhou; Geng Ku; Laura Pageon; Chun Li
Journal:  Nanoscale       Date:  2014-11-07       Impact factor: 7.790

7.  A chelator-free multifunctional [64Cu]CuS nanoparticle platform for simultaneous micro-PET/CT imaging and photothermal ablation therapy.

Authors:  Min Zhou; Rui Zhang; Miao Huang; Wei Lu; Shaoli Song; Marites P Melancon; Mei Tian; Dong Liang; Chun Li
Journal:  J Am Chem Soc       Date:  2010-11-03       Impact factor: 15.419

8.  Role of surgical outcome as prognostic factor in advanced epithelial ovarian cancer: a combined exploratory analysis of 3 prospectively randomized phase 3 multicenter trials: by the Arbeitsgemeinschaft Gynaekologische Onkologie Studiengruppe Ovarialkarzinom (AGO-OVAR) and the Groupe d'Investigateurs Nationaux Pour les Etudes des Cancers de l'Ovaire (GINECO).

Authors:  Andreas du Bois; Alexander Reuss; Eric Pujade-Lauraine; Philipp Harter; Isabelle Ray-Coquard; Jacobus Pfisterer
Journal:  Cancer       Date:  2009-03-15       Impact factor: 6.860

9.  Ultra-low doses of chirality sorted (6,5) carbon nanotubes for simultaneous tumor imaging and photothermal therapy.

Authors:  Alexander L Antaris; Joshua T Robinson; Omar K Yaghi; Guosong Hong; Shuo Diao; Richard Luong; Hongjie Dai
Journal:  ACS Nano       Date:  2013-04-03       Impact factor: 15.881

10.  Integrated analysis of germline and somatic variants in ovarian cancer.

Authors:  Krishna L Kanchi; Kimberly J Johnson; Charles Lu; Michael D McLellan; Mark D M Leiserson; Michael C Wendl; Qunyuan Zhang; Daniel C Koboldt; Mingchao Xie; Cyriac Kandoth; Joshua F McMichael; Matthew A Wyczalkowski; David E Larson; Heather K Schmidt; Christopher A Miller; Robert S Fulton; Paul T Spellman; Elaine R Mardis; Todd E Druley; Timothy A Graubert; Paul J Goodfellow; Benjamin J Raphael; Richard K Wilson; Li Ding
Journal:  Nat Commun       Date:  2014       Impact factor: 14.919

View more
  6 in total

1.  Radiolabeling of Theranostic Nanosystems.

Authors:  Sudeep Das; Surachet Imlimthan; Anu J Airaksinen; Mirkka Sarparanta
Journal:  Adv Exp Med Biol       Date:  2021       Impact factor: 2.622

2.  Induction of antitumor immunity in mice by the combination of nanoparticle-based photothermolysis and anti-PD-1 checkpoint inhibition.

Authors:  Qizhen Cao; Wanqin Wang; Min Zhou; Qian Huang; Xiaoxia Wen; Jun Zhao; Sixiang Shi; Ku Geng; Fenge Li; Hiroto Hatakeyama; Chunyu Xu; David Piwnica-Worms; Weiyi Peng; Dapeng Zhou; Anil K Sood; Chun Li
Journal:  Nanomedicine       Date:  2020-02-12       Impact factor: 5.307

Review 3.  Radiolabeled inorganic nanoparticles for positron emission tomography imaging of cancer: an overview.

Authors:  Rubel Chakravarty; Shreya Goel; Ashutosh Dash; Weibo Cai
Journal:  Q J Nucl Med Mol Imaging       Date:  2017-01-26       Impact factor: 2.346

4.  Osteotropic Radiolabeled Nanophotosensitizer for Imaging and Treating Multiple Myeloma.

Authors:  Rui Tang; Alexander Zheleznyak; Matthew Mixdorf; Anchal Ghai; Julie Prior; Kvar C L Black; Monica Shokeen; Nathan Reed; Pratim Biswas; Samuel Achilefu
Journal:  ACS Nano       Date:  2020-04-06       Impact factor: 15.881

5.  The combined therapeutic effects of 131iodine-labeled multifunctional copper sulfide-loaded microspheres in treating breast cancer.

Authors:  Qiufang Liu; Yuyi Qian; Panli Li; Sihang Zhang; Zerong Wang; Jianjun Liu; Xiaoguang Sun; Michael Fulham; Dagan Feng; Zhigang Chen; Shaoli Song; Wei Lu; Gang Huang
Journal:  Acta Pharm Sin B       Date:  2018-04-07       Impact factor: 11.413

6.  131I-Labeled Copper Sulfide-Loaded Microspheres to Treat Hepatic Tumors via Hepatic Artery Embolization.

Authors:  Qiufang Liu; Yuyi Qian; Panli Li; Sihang Zhang; Jianjun Liu; Xiaoguang Sun; Michael Fulham; Dagan Feng; Gang Huang; Wei Lu; Shaoli Song
Journal:  Theranostics       Date:  2018-01-01       Impact factor: 11.556

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.